Skip to main content
. 2020 Aug 20;89(1):175–184. doi: 10.1038/s41390-020-01106-w

Table 5.

Relative risks for short-term morbidities affected by NAC and NNTs for benefit.

Outcome Relative risk [95% CI] P value NNT [95% CI]
Composite morbidity scorea ≥2 0.451 [0.213–0.952] 0.037 3.869 [2.095–25.227]
IVH 0.396 [0.159–0.978] 0.047 4.332 [2.295–38.675]
IVH and/or death 0.364 [0.164–0.808] 0.013 3.143 [1.878–9.623]
BPD 0.100 [0.014–0.735] 0.024 3.444 [2.145–8.741]
BPD and/or death 0.238 [0.075–0.759] 0.015 3.431 [2.069–10.047]

NAC N-acetylcysteine, IVH intraventricular hemorrhage, BPD bronchopulmonary dysplasia, CI confidence interval, NNT number needed to treat.

aComposite of culture-proven sepsis (any type), IVH grades 3 and 4, ROP grades 2–4, NEC grades 2–4, PVL, BPD, and/or death.